Location: Home
  • search
  • go
  • Relate News
  • 6/4/2020USTR Satisfied with China's Implementatin of Phase 1 US-China Trade De...
  • 6/4/2020Beijing Plans to Criminalize Criticisms of Traditional Chinese Medicin...
  • 6/4/2020Everest Medicines Completes $310 Million Series C Financing
  • 6/3/2020Oncodesign Establishes Strategic Alliance with HitGen to Strengthen It...
  • 6/3/2020BeiGene Announces the Approval of BRUKINSA (Zanubrutinib) in China
  • 6/3/2020Stada Eyes Increased API Sourcing from and Presence in China
  • 6/3/2020CDE Seeks Comments on Draft ICH Guideline Q12
  • 6/3/2020Sanofi Genzyme's Aldurazyme Approved in China through Priority Review
  • 6/3/2020Harbour BioMed Announces IND Approval for HBM9161 by NMPA
  • 6/3/2020Innovent Announces the Preliminary Results of the Anti-CTLA-4 Monoclon...
  • 6/3/2020Dealing with the Chinese Economy after COVID-19
  • 6/2/2020CDE Solicits Feedbacks on Draft Technical Guidance for Package Integri...
  • 6/2/2020CDE Solicits Feedbacks on Draft Technical Guidance for Plastic Compone...
  • 6/1/2020Inventiva Secures A New Patent for lanifibranor in China
  • 6/1/2020Genor Pharma Raises $160M in Series B Funding
  • 6/1/2020Henlius and Accord Receive Positive CHMP Opinion for Biosimilar HLX02 ...
  • 6/1/2020Chi-Med Plans to Submit NDA for Surufatinib Following Pre-NDA Meeting ...
  • 6/1/2020Chinese Antitrust Authority Imposes Maximum Fine In Rare Abuse Of Coll...
  • 6/1/2020AbbVie and Jacobio Pharma Enter Parternership for Anticancer SHP2 Inhi...
  • 6/1/2020Junshi Biosciences, Merck Partner on SCCHN Combo Therapy
  • 6/1/2020Despite Stormy Days Ahead, Pockets of Hope and Opportunity Remain
  • 6/1/2020CDE Solicits Comments on Two Draft Documents for Phase I Clinical Tria...
  • 6/1/2020EMA Accepts First Application for Chinese-made Biosimilar HLX02
  • 5/29/2020NMPA Issues List of Reference Formulations for Generic Drug Equivalenc...
  • 5/29/2020Recent Executive Moves
  • 5/29/2020Financial-related Company News in Brief
  • 5/28/2020Challenges Posed to Chinese Biotechs in Post-Pandemic Era
  • 5/28/2020New Report: China Pharmaceutical Distribution Industry Report to 2026
  • 5/28/2020SMEI Bluebook 2020: Chinese Retail Pharmacy Market (Offline and Online...
  • 5/28/2020SMEI Bluebook 2020: Urban and County Level Public Hospital Drug Market...
  • Page:234/774 Total number of articles:23193: [First][<<] [232] [233] [234] [235] [236] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group